510(k) Report

510(k) · Cleared

Cleared

Accu-Chek Advisor Insulin Guidance Software

K043529510(k) TraditionalCleared Apr 8, 2005108-day reviewClass II21 CFR 868.1890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · NDC Calculator, Drug Dose

Cleared on Apr 8, 2005 after a 108-day review. The FDA summary names its predicate without a number. 10 later devices descend from it.

Decided
Apr 8, 2005
Review
108 days
Class
Class II
Product code
NDC
Recalls
None
Predicates
0

10 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2011: 1 descendant cleared2016: 1 descendant cleared2017: 1 descendant cleared2013: 1 descendant cleared2019: 1 descendant cleared2020: 1 descendant cleared2023: 2 descendants cleared2021: 1 descendant cleared20052010201520202025
  1. This deviceK043529 Accu-Chek Advisor Insulin Guidance SoftwareRoche Diagnostics Corp. · 2005
  2. Descendant · cites it directly · 8 of its ownK100066 Diabetesmanager System, Diabetesmanager-RX System Model Version 1.1Welldoc, Inc. · 2010
  3. Descendant · 2 generations on · 5 of its ownK162532 WellDoc BlueStar, WellDoc BlueStar RxWelldoc, Inc. · 2017
  4. Descendant · 3 generations on · 4 of its ownK190013 WellDoc BlueStarWelldoc, Inc. · 2019
  5. Descendant · 4 generations on · 3 of its ownK193654 BlueStar RxWelldoc, Inc. · 2020
  6. Descendant · 5 generations on · 1 of its ownK203434 BlueStar RxWelldoc, Inc. · 2021

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2010: 12011: 12013: 12016: 12017: 12019: 12020: 12021: 12023: 2
2010high 2 (2023) · low 0 (2012)2026

Most influential descendants

Showing 5 of 10 · See all
  • K100066Diabetesmanager System, Diabetesmanager-RX System Model Version 1.1Welldoc, Inc. · 2010 · cites it directly8descendants
  • K162532WellDoc BlueStar, WellDoc BlueStar RxWelldoc, Inc. · 2017 · 2 generations on5descendants
  • K190013WellDoc BlueStarWelldoc, Inc. · 2019 · 3 generations on4descendants
  • K193654BlueStar RxWelldoc, Inc. · 2020 · 4 generations on3descendants
  • K203434BlueStar RxWelldoc, Inc. · 2021 · 5 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K043529Accu-Chek Advisor Insulin Guidance SoftwareRoche Diagnostics Corp.2005—
+1K100066Diabetesmanager System, Diabetesmanager-RX System Model Version 1.1Welldoc, Inc.2010—
+2K162532WellDoc BlueStar, WellDoc BlueStar RxWelldoc, Inc.2017—
+3K190013WellDoc BlueStarWelldoc, Inc.2019—
+4K193654BlueStar RxWelldoc, Inc.2020—
+5K203434BlueStar RxWelldoc, Inc.2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201110
201310
201610
201710
201910
202010
202110
202320
FIG. 1 — Lineage of K043529, 2005–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NDC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NDC device

  1. #1 K242775 InPen System App (MMT-8060 (iOS), MMT-8061…score 18.0 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Diacare Monitoring System Software
Named without a submission number
—

What descends from it? (10)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K100066Diabetesmanager System, Diabetesmanager-RX System Model Version 1.1Welldoc, Inc.20108
K103643Ascot Home Medical Monitoring System (HMMS)Ascot Technologies, Inc.20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K100066 (Welldoc, Inc., 2010) has gone furthest, with 8 descendants of its own.

How does its category compare?

All NDC devices

NDC Calculator, Drug Dose: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NDC

2in 2025

2007: 12008: 22010: 12012: 22014: 32015: 32016: 22017: 82018: 32019: 12020: 52021: 32023: 32024: 32025: 22026 (partial year): 4
2007high 8 (2017) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NDC

60in 2024

2014: 118 days median2015: 199 days median2017: 189 days median2018: 220 days median2020: 53 days median2021: 269 days median2023: 126 days median2024: 60 days median2026 (partial year): 90 days median
2007high 269 (2021) · low 53 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NDC

1in 2025

2016: 12017: 22018: 12019: 12022: 12025: 12026 (partial year): 2
2007high 2 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NDC

299in 2025

2008: 72009: 42010: 182011: 112012: 22013: 12014: 12015: 12016: 182017: 252018: 212019: 182020: 102021: 112022: 3472023: 4632024: 1682025: 299
2007high 463 (2023) · low 0 (2007)2025

MAUDE reports naming product code NDC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—07
20090—04
20101—018
20110—011
20122—02
20130—01
2014311801
2015319901
20162—118
20178189225
20183220121
20191—118
2020553010
20213269011
20220—1347
202331260463
20243600168
20252—1299
20264902—

What is it indicated for?

The software is intended for use in home and clinical settings to aid people with diabetes and their health care professionals in review, analysis and evaluation of historical blood glucose test results to support effective diabetes management, including providing direction within the scope of a pre-planned treatment program for adjustments to prescribed insulin, similar to the directions physicians provide to patients as a part of routine clinical practice. The device is not intended to provide any diagnosis on patient results.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K043529: Accu-Chek Advisor Insulin Guidance Software.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K043529

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026